NOV anticorps (AA 221-320) (Biotin)
Aperçu rapide pour NOV anticorps (AA 221-320) (Biotin) (ABIN761818)
Antigène
Voir toutes NOV AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 221-320
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human IGFBP9/CCN3
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- NOV (Nephroblastoma Overexpressed (NOV))
-
Autre désignation
- IGFBP9
-
Sujet
-
Synonyms: CCN3, NOVh, IBP-9, IGFBP9, IGFBP-9, Protein NOV homolog, CCN family member 3, Insulin-like growth factor-binding protein 9, IGF-binding protein 9, Nephroblastoma-overexpressed gene protein homolog, NOV
Background: Immediate-early protein likely to play a role in cell growth regulation.
-
ID gène
- 4856
-
UniProt
- P48745
-
Pathways
- Smooth Muscle Cell Migration, Growth Factor Binding
Antigène
-